REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 401 filers reported holding REPLIGEN CORP in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,584,707 | -48.4% | 244,484 | -38.6% | 0.26% | -56.2% |
| Q1 2023 | $67,007,785 | +191.9% | 398,003 | +181.6% | 0.59% | +123.2% |
| Q2 2022 | $22,956,000 | +523.6% | 141,357 | +622.3% | 0.26% | +541.5% |
| Q1 2022 | $3,681,000 | +170.3% | 19,571 | -40.4% | 0.04% | +272.7% |
| Q2 2017 | $1,362,000 | – | 32,863 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |